SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Treatment hope for cognitive symptoms in Parkinson's disease
Tues May 17th - Ultra-powerful 7T MRI scanners could help to identify those patients with conditions such as Parkinson's disease who would benefit from new treatments for cognitive symptoms that were previously untreatable, British researchers report today. More
E-cigarettes as effective as patches for pregnant women
Tues May 17th - E-cigarettes can help pregnant women to stop smoking and are as safe as nicotine patches, according to new UK research. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
OUR CLIENTS
THIS WEEK'S STORIES
ENGLEMED HEALTH NEWS

Measles outbreak threat as COVID-19 scuppers vaccine programmes

Thursday November 11th 2021

The risk of measles outbreaks is increasing while efforts to eliminate the disease continue to decline, a new report from the World Health Organization and US Centers for Disease Control and Prevention (CDC) has warned.

The report, published yesterday, reveals that in 2020, more than 22 million infants missed their first dose of measles vaccine, three million more than in 2019, which is the largest increase in two decades.

Measles surveillance also deteriorated, with the lowest number of specimens sent for laboratory testing in more than ten years, while major measles outbreaks occurred in 26 countries, accounting for 84% of all reported cases in 2020.

Dr Kevin Cain, CDC’s global immunisation director, said: “Large numbers of unvaccinated children, outbreaks of measles, and disease detection and diagnostics diverted to support COVID-19 responses are factors that increase the likelihood of measles-related deaths and serious complications in children.

“We must act now to strengthen disease surveillance systems and close immunity gaps, before travel and trade return to pre-pandemic levels, to prevent deadly measles outbreaks and mitigate the risk of other vaccine-preventable diseases.”

The research found first-dose coverage fell in 2020, and 70% of children received their second dose measles vaccine, well below the 95% coverage needed to protect communities from the spread of the measles virus.

It also calculated that 24 measles vaccination campaigns in 23 countries were postponed in 2020 because of the COVID-19 pandemic.

Dr Kate O’Brien, director of WHO’s Department of Immunisation, Vaccines and Biologicals, said: “While reported measles cases dropped in 2020, evidence suggests we are likely seeing the calm before the storm as the risk of outbreaks continues to grow around the world.

“It’s critical that countries vaccinate as quickly as possible against COVID-19, but this requires new resources so that it does not come at the cost of essential immunisation programmes. Routine immunisation must be protected and strengthened; otherwise, we risk trading one deadly disease for another.”

In the last 20 years, the measles vaccine is estimated to have averted more than 30 million deaths globally, with estimated deaths dropping from about 1.07 million in 2000 to 60,700 in 2020.

The estimated number of measles cases in 2020 was 7.5 million globally.

By the end of 2020, 81 countries had succeeded in sustaining their measles elimination status despite the pandemic, but no new countries were verified as having achieved measles elimination.

There are still 15 countries that have not introduced the measles second dose into their national immunisation schedules.

Ephrem Tekle Lemango, UNICEF associate director for immunisation, said: “Even before the pandemic, we were seeing how even small pockets of low measles immunisation coverage could fuel unprecedented outbreaks, including in countries where the disease had been considered eradicated.

“And now, COVID-19 is creating widening gaps in coverage at a pace we haven’t seen in decades. While we have not seen an increase in cases yet, measles is simply too contagious. If we do not act, gaps will become outbreaks, and many children will be exposed to a preventable but potentially deadly disease.”

Tags: Child Health | Flu & Viruses | North America | World Health

Printer friendly page Printer friendly page

Comment on this article:

Name:
Email:
Comment:
<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)
CATEGORIES